In the last step, the sensitivity of confocal tissue imaging was exploited to challenge PSMA-914 specificity and to quantitatively investigate potential tracer enrichment at the target dose of 5 nmol in non-target tissue, specifically muscle tissue and PSMA-negative tumor tissue, based on the integrated PSMA-914 fluorescence intensity. The gene discussed is FOLH1; the disease is neoplasm.